Coronavirus disease (COVID-19) Pandemic
On this page you’ll find answers to frequently asked questions about mRNA vaccines.
All about the vaccines - briefly and concisely explained
Vaccines: Rapid solution for new diseases?
Swismedic - The way a vaccination works
How an mRNA vaccine works
How a vector vaccine works?
How a protein vaccine works
How is the safety of vaccines monitored?
Communication regarding COVID-19
20.10.2021
Licences in accordance with art. 22 para. 3 of the COVID 19 Ordinance 3
19.10.2021
Vaccine candidate CVnCoV no longer in rolling review procedure
15.10.2021
8,757 reports of suspected adverse vaccination reactions (ADR) evaluated – the overall positive benefit-risk ratio of the vaccines remains
01.10.2021
Vector vaccine as an alternative to mRNA vaccines
24.09.2021
7,571 reports evaluated – the overall positive benefit-risk ratio of the vaccines remains
23.09.2021
Swissmedic takes action against dispensing of non-compliant rapid tests by Swiss online shops
21.09.2021
Extension of the shelf-life at ultralow temperature
16.09.2021
Pfizer Schweiz AG and Moderna Switzerland GmbH have submitted applications for a third vaccine dose (booster)
03.09.2021
6,603 reports evaluated – the overall positive benefit-risk ratio of the vaccines remains
30.08.2021
Federal Office of Public Health (FOPH) lists the certified self-tests
